Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Review Status	Status Date	View
CYSB2101050	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2021-04-23	Gan & Lee Pharmaceuticals			view
JYSB1100219	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2011-09-29	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2012-08-16	view
CYSB2300212	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2023-11-22	Sanofi (Beijing) Pharmaceuticals Co Ltd			view
CYSB2101051	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2021-04-27	Gan & Lee Pharmaceuticals			view
CYSB2400140	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-06-01	Gan & Lee Pharmaceuticals			view
JYSB2101113	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2021-08-26	Sanofi-Aventis Deutschland GmbH			view
CYSB2300078	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2023-04-05	Gan & Lee Pharmaceuticals			view
CYSB2101083	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2021-06-03	Sanofi (Beijing) Pharmaceuticals Co Ltd			view
JYSB2400079	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-04-08				view
CYSB2200117	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2022-05-18	Tonghua Dongbao Pharmaceutical Co Ltd			view
CYSB2400237	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-09-13	Zhuhai United Laboratories Co Ltd			view
JXSS2200043	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.3)	Import Drug Application	2022-12-27				view
CXSB2101014	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2021-05-21	Gan & Lee Pharmaceuticals			view
CYSB2400141	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-06-01	Gan & Lee Pharmaceuticals			view
CXSS2200079	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.3)	New Drug Application	2022-09-17	Hefei Tianmai BIOTECHNOLOGY Development Co Ltd			view
JYSZ2300012	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	License Renew	2023-02-28				view
CYSB2101082	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2021-06-03	Sanofi (Beijing) Pharmaceuticals Co Ltd			view
CYSB2400040	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-02-09	Gan & Lee Pharmaceuticals			view
CYSB2101101	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2021-06-21	Tonghua Dongbao Pharmaceutical Co Ltd			view
JYSZ2400051	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	License Renew	2024-09-04				view